Docosanol
二十二醇
Report date: 2023/01/13 20:00:32
NMEFirst In Class
Base Information
Drug NameDocosanol
Drug Alias Name +[15]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A
Develop Information
Active CompaniesHaleon PLC
Inactive CompaniesUtah State UniversityLaboratoire Boreaderme Inc
Active Indications
Inactive Indications